Billy Kawasaki’s Insights - Billy’s most-liked answers from 5i Research. Quarter was good. Revenue grew 77%, beat estimates by 10% and EPS more than doubled to 8 cents, beating estimates by 25%. The company made five acquisitions year to date and organic growth was decent at 7%. Cash flow conversion was strong at 82%. Backlog looked healthy and showed good growth. Gross margins came down slightly, but management expects them to rise in the next quarter due to more software sales expected. Management also noted improvements on the supply chain side with regards to hardware deliverables from 4-6 months to 2-3 months (normally 4-6 weeks). Overall, CTS is well-positioned. No major concerns about the quarter. Negative momentum on the stock is more market-related than company-specific. Unlock Premium - Try 5i Free
(A Top Pick May 11/21, Up 27%) Management team executing very well. Expecting the company to grow organically and through M&A. Once interest rates & market volatility reduces, expecting stock price to rise.
Billy Kawasaki’s Insights - Billy’s most-liked answers from 5i Research. Continues to view the name positively.The weakness is probably from the bad market for tech and growth than with the company itself. Benefits from many tailwinds such as organisations transforming their data processes. Acquisition strategy is very disciplined. Unlock Premium - Try 5i Free
Billy Kawasaki’s Insights - Billy’s most-liked answers from 5i Research. Continues to like this company. Remains a profitable tech consulting company with strong growth. Cash position is strong and valuation is cheap. Management is disciplined and their acquisition strategy is clear. Good upside is expected over the next few years. Could see multiple expansion. Unlock Premium - Try 5i Free
Billy Kawasaki’s Insights - Billy’s most-liked answers from 5i Research. Their growth strategy is primarily acquisitive. They also see tailwinds from rising demand for software and IT services. Management has a clear plan and has met targets well. There is room for greater institutional ownership over time. Unlock Premium - Try 5i Free
Converge Technology Solutions is a Canadian stock, trading under the symbol CTS-T on the Toronto Stock Exchange (CTS-CT). It is usually referred to as TSX:CTS or CTS-T
In the last year, 18 stock analysts published opinions about CTS-T. 16 analysts recommended to BUY the stock. 1 analyst recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for Converge Technology Solutions.
Converge Technology Solutions was recommended as a Top Pick by on . Read the latest stock experts ratings for Converge Technology Solutions.
Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.
18 stock analysts on Stockchase covered Converge Technology Solutions In the last year. It is a trending stock that is worth watching.
On 2022-07-07, Converge Technology Solutions (CTS-T) stock closed at a price of $5.26.